Screener
Adaptive Biotechnologies ADPT Other Non-Current Liabilities
Other Non-Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Adaptive Biotechnologies in its filing.
Tagged under the XBRL concept us-gaap:OtherLiabilitiesNoncurrent.
The source filing: Adaptive Biotechnologies’s 10-Q, filed May 5, 2026.
- Filed
- May 5, 2026, 4:30 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-206546
| Line item | March 31, 2026 | December 31, 2025 |
|---|---|---|
| Operating lease liabilities, less current portion | 69,115 | 70,228 |
| Deferred revenue, less current portion | 807 | 1,006 |
| Revenue interest liability, net, less current portion | 124,749 | 126,566 |
| Other long-term liabilities | 20 | 20 |
| Total liabilities | 281,702 | 287,735 |
| Commitments and contingencies (Note 9) | ||
| Shareholders’ equity | ||
| Preferred stock: $0.0001 par value, 10,000,000 shares authorized at March 31, 2026 and December 31, 2025; no shares issued and outstanding at March 31, 2026 and December 31, 2025 | — | — |
Item 1. Financial Statements (Unaudited)
FAQ
- What is Adaptive Biotechnologies's other non-current liabilities?
- Adaptive Biotechnologies (ADPT) reported other non-current liabilities of $20K in Q1 2026.
- How has Adaptive Biotechnologies's other non-current liabilities changed year-over-year?
- Adaptive Biotechnologies's other non-current liabilities decreased by 0.0% year-over-year, from $20K to $20K.
- What does other non-current liabilities mean?
- Miscellaneous long-term obligations not classified in specific categories — pension liabilities, environmental remediation, and other long-term accruals.
Ask your AI about Adaptive Biotechnologies's other non-current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude